AstraZeneca’s AZD6793 holds potential to expand oral COPD treatment options, says GlobalData Read more
AstraZeneca launches K+ Connect to advance hyperkalemia management in heart failure, chronic kidney disease across India Read more
India overtakes Iran in clinical trial initiations outside North America and Europe in Q2 2025 Read more